Bailard’s Opko Health OPK Stock Holding History

Bailard’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,700	Closed	-$45.9K	–	789
2023 Q3	$45.9K	Hold	28,700	–	–	﹤0.01%	691
2023 Q2	$62.3K	Buy	+28,700	New	+$44.9K	﹤0.01%	675

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bailard's OPK Position: Q4 2023 in Review

Bailard sold out of Opko Health (OPK) in Q4 2023, closing a stake of 28,700 shares — an estimated $45.9K sold.

Bailard first reported a position in OPK in Q2 2023 and held it in 2 quarters. The position peaked at $62.3K in Q2 2023. 218 funds tracked by Wall St. Rank hold OPK as of Q4 2023.

Bailard reported no remaining Opko Health position as of Q4 2023 after selling out during the quarter.
Bailard sold 28,700 Opko Health shares in Q4 2023, an estimated $45.9K.
Bailard first reported a position in Opko Health in Q2 2023 and held it in 2 quarters.
Bailard's Opko Health position peaked at $62.3K in Q2 2023.
218 funds tracked by Wall St. Rank held Opko Health as of Q4 2023.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.